CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

Go back to CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.61 -0.04 (1.1%)
Previous Close $3.65    52 Week High $24.68 
Open $3.66    52 Week Low $9.10 
Day High $3.66    P/E N/A 
Day Low $3.59    EPS $0.00 
Volume 129,472       

Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 138.96 -1.37 (0.98%)
Previous Close $140.33    52 Week High $0.52 
Open $140.30    52 Week Low $0.08 
Day High $143.94    P/E N/A 
Day Low $136.70    EPS $-3.80 
Volume 2,187,854